118 related articles for article (PubMed ID: 2327181)
1. [Soluble interleukin 2 receptor (sIL-2R) in chronic polyarthritis].
Herzog C; Herzog A; Aeschlimann A; Gerber H; Müller W
Z Rheumatol; 1990; 49(1):8-10. PubMed ID: 2327181
[TBL] [Abstract][Full Text] [Related]
2. Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.
Symons JA; Wood NC; Di Giovine FS; Duff GW
J Immunol; 1988 Oct; 141(8):2612-8. PubMed ID: 3262665
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of cytokine receptors sTNF-R55, sTNF-R75, and sIL-2R in psoriatic arthritis synovial fluid.
Partsch G; Wagner E; Leeb BF; Dunky A; Steiner G; Smolen JS
J Rheumatol; 1998 Jan; 25(1):105-10. PubMed ID: 9458212
[TBL] [Abstract][Full Text] [Related]
4. [The significance of soluble IL-2 receptors in rheumatoid arthritis with interstitial pneumonia].
Tada S; Namba J; Yokota S; Sugimoto K; Imajo K; Kawabata H; Irie S; Kimura I; Kitani H; Tanizaki K
Arerugi; 1992 Mar; 41(3):428-33. PubMed ID: 1575640
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-2 receptor levels in sera of patients with rheumatoid arthritis treated with sulfasalazine, parenteral gold, or placebo.
Merkel PA; Dooley MA; Dawson DV; Pisetsky DS; Polisson RP
J Rheumatol; 1996 Nov; 23(11):1856-61. PubMed ID: 8923356
[TBL] [Abstract][Full Text] [Related]
6. The effects of nonsteroidal antiinflammatory drug therapy in early rheumatoid arthritis on serum levels of soluble interleukin 2 receptor, CD4, and CD8.
Dooley MA; Cush JJ; Lipsky PE; Dawson DV; Pisetsky DS
J Rheumatol; 1993 Nov; 20(11):1857-62. PubMed ID: 8308770
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 1 in rheumatoid arthritis: potentiation of immune responses within the joint.
Symons JA; McDowell TL; di Giovine FS; Wood NC; Capper SJ; Duff GW
Lymphokine Res; 1989; 8(3):365-72. PubMed ID: 2789325
[TBL] [Abstract][Full Text] [Related]
8. Influence of corticosteroid pulse therapy on the serum levels of soluble interleukin 2 receptor, interleukin 6 and interleukin 8 in patients with rheumatoid arthritis.
van den Brink HR; van Wijk MJ; Geertzen RG; Bijlsma JW
J Rheumatol; 1994 Mar; 21(3):430-4. PubMed ID: 7911833
[TBL] [Abstract][Full Text] [Related]
9. Cytokines and soluble interleukin 2 receptors in rheumatoid arthritis.
Wolf RE; Brelsford WG; Hall VC; Adams SB
J Rheumatol; 1992 Apr; 19(4):524-8. PubMed ID: 1593571
[TBL] [Abstract][Full Text] [Related]
10. [Soluble IL-2 receptor levels in rheumatic diseases].
Takaya M; Ichikawa Y; Shimizu H; Uchiyama M; Moriuchi J; Arimori S
Ryumachi; 1993 Jun; 33(3):229-34. PubMed ID: 8346465
[TBL] [Abstract][Full Text] [Related]
11. Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies.
Usón J; Balsa A; Pascual-Salcedo D; Cabezas JA; Gonzalez-Tarrio JM; Martín-Mola E; Fontan G
J Rheumatol; 1997 Nov; 24(11):2069-75. PubMed ID: 9375862
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6, soluble interleukin-2-receptor and soluble interleukin-6-receptor in sera of patients with rheumatoid arthritis: influences of disease activity and drug therapy.
Franke S; Herrmann D; Hein G; Müller A; Stein G
Eur J Med Res; 1997 Sep; 2(9):401-6. PubMed ID: 9300938
[TBL] [Abstract][Full Text] [Related]
13. Anti-Fc gamma receptor III autoantibody is associated with soluble receptor in rheumatoid arthritis serum and synovial fluid.
Lamour A; Baron D; Soubrane C; Cartron J; Khayat D; Adler Y; Le Goff P; Youinou P
J Autoimmun; 1995 Apr; 8(2):249-65. PubMed ID: 7612151
[TBL] [Abstract][Full Text] [Related]
14. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
Mathsson L; Lampa J; Mullazehi M; Rönnelid J
Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
[TBL] [Abstract][Full Text] [Related]
15. Pleural fluid soluble interleukin 2 receptor in rheumatoid arthritis and systemic lupus erythematosus.
Pettersson T; Söderblom T; Nyberg P; Riska H; Linko L; Klockars M
J Rheumatol; 1994 Oct; 21(10):1820-4. PubMed ID: 7837144
[TBL] [Abstract][Full Text] [Related]
16. High levels of interleukin 13 in rheumatoid arthritis sera are modulated by tumor necrosis factor antagonist therapy: association with dendritic cell growth activity.
Tokayer A; Carsons SE; Chokshi B; Santiago-Schwarz F
J Rheumatol; 2002 Mar; 29(3):454-61. PubMed ID: 11908556
[TBL] [Abstract][Full Text] [Related]
17. Synovial fluid expression of autoantibodies specific for RAGE relates to less erosive course of rheumatoid arthritis.
Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A
Rheumatology (Oxford); 2007 Aug; 46(8):1367-71. PubMed ID: 17569744
[TBL] [Abstract][Full Text] [Related]
18. Soluble interleukin-2 receptor in sera and synovial fluids of rheumatoid patients: correlations with disease activity.
Carotti M; Salaffi F; Ferraccioli GF; Binci MC; Sartini A; Cervini C
Rheumatol Int; 1994; 14(2):47-52. PubMed ID: 7824835
[TBL] [Abstract][Full Text] [Related]
19. Serial soluble interleukin 2 receptor levels in rheumatoid arthritis: differences in response to glucocorticoid treatment and chrysotherapy.
Kirkham BW; Davison SC; Corkill MM; Barbatis C; Panayi GS
J Rheumatol; 1993 Jun; 20(6):935-9. PubMed ID: 8350327
[TBL] [Abstract][Full Text] [Related]
20. [The serum level of soluble interleukin-2 receptors in patients with rheumatoid arthritis].
Medvedev AN; Korshunov NI; Nasonov EL; Baranov AA; Shilkina NP
Ter Arkh; 1996; 68(5):24-7. PubMed ID: 9082592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
